St. Jude Medical PressureWire helped reduce the risk of urgent revascularization by more than eleven times in patients with stable coronary artery disease compared to medical treatment alone ST. PAUL, ...

PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with stable angina.

Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...

Researchers have found in a new study that coronary revascularization of chronic total occlusion (CTO) using PCI ...

Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs. optimal medical therapy alone in patients with CAD and HF. Intervention conferred ...

City Council members here rarely respond to citizens who comment during a council meeting's public-comment period. But on Tuesday evening, council member Monica Vernon used what the council calls “a ...

In patients with non–flow-limiting vulnerable plaques, percutaneous coronary intervention (PCI) plus optimal medical therapy reduced the risk for adverse cardiac events and death compared with optimal ...

NEJM publishes data demonstrating St. Jude Medical PressureWireTM FFR can reduce urgent revascularization and adverse cardiac events ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc., a ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...